Clinical Trials Browser

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Sarcoma, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT05919108 2025-09-09

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Phase 2 Recruiting

30 enrolled

Carcinoma, Lobular

NCT05463796 2025-08-07

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Recruiting

5,000 enrolled

GastrointestinalGynecologicOther hematologic neoplasmThoracic

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

NCT06067503 2025-04-22

Biomarkers to Detect Endocrine Therapy Resistance

Phase 2 Recruiting

8 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

Clinical Trials

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)

LBC-Monitor

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Biomarkers to Detect Endocrine Therapy Resistance